BEAT Stock Overview
HeartBeam, Inc., a medical technology company, primarily focuses on developing and commercializing ambulatory electrocardiogram solutions that enable the detection and monitoring of cardiac disease inside and outside a healthcare facility setting.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
HeartBeam, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$2.01 |
| 52 Week High | US$3.74 |
| 52 Week Low | US$1.06 |
| Beta | -1.22 |
| 1 Month Change | -7.80% |
| 3 Month Change | 7.49% |
| 1 Year Change | -1.95% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -57.14% |
Recent News & Updates
Recent updates
Companies Like HeartBeam (NASDAQ:BEAT) Could Be Quite Risky
Jan 17
HeartBeam gets a new chief medical officer
Oct 11HeartBeam gets patent to enable generation of its credit card-sized ECG, shares rise ~15%
Sep 28HeartBeam surges 54% on U.S. patent for ECG patch monitor to detect heart attacks
Sep 15HeartBeam GAAP EPS of $0.43 beats by $0.70
Aug 11HeartBeam: Cardiovascular Diagnostics On The Go
Dec 14Shareholder Returns
| BEAT | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -1.5% | -0.9% | -0.7% |
| 1Y | -2.0% | -2.0% | 22.3% |
Return vs Industry: BEAT matched the US Medical Equipment industry which returned -1.4% over the past year.
Return vs Market: BEAT underperformed the US Market which returned 22.8% over the past year.
Price Volatility
| BEAT volatility | |
|---|---|
| BEAT Average Weekly Movement | 13.1% |
| Medical Equipment Industry Average Movement | 7.4% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 16.7% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: BEAT's share price has been volatile over the past 3 months.
Volatility Over Time: BEAT's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2015 | 15 | Branislav Vajdic | www.heartbeam.com |
HeartBeam, Inc., a medical technology company, primarily focuses on developing and commercializing ambulatory electrocardiogram solutions that enable the detection and monitoring of cardiac disease inside and outside a healthcare facility setting. The company develops three-dimensional vector images of cardiac electrical activity. It is developing HeartBeam AIMIGo, a credit card-sized cloud-based diagnostic software systems to address heart attack detection.
HeartBeam, Inc. Fundamentals Summary
| BEAT fundamental statistics | |
|---|---|
| Market cap | US$53.05m |
| Earnings (TTM) | -US$14.64m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-3.6x
P/E RatioIs BEAT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BEAT income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$14.64m |
| Earnings | -US$14.64m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 09, 2024
| Earnings per share (EPS) | -0.55 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0% |
How did BEAT perform over the long term?
See historical performance and comparison